where is retatrutide approved Some Providers Prescribe Unapproved for Weight Loss at Alarming Rate How Much BAC Water for

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC), 2326 October 2023: GLP-1 receptor agonists available evidence not supporting link with thyroid cancer

What should I do if my pet chews a GLP-1 injection pen

Semaglutide and tirzepatide do not damage hair follicles

Davidson IWF, Salter JM, Best CH

Whether a reduced incretin effect (reduced beta cell sensitivity to GIP and/or GLP-1) may play a role in the pathophysiology of NAFLD warrants further investigations

Your healthcare team will schedule regular reviews to monitor your response and make evidence-based decisions about dose optimisation, ensuring you receive maximum benefit whilst minimising risks